LOS ANGELES, July 22, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of 4D Molecular Therapeutics, Inc. ("4D Molecular Therapeutics" or "the Company") (NASDAQ: FDMT) for violations of the securities laws. If you are a shareholder who suffered a loss, click here to participate. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder r ...